GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RLS Global AB (OSTO:RLS) » Definitions » EV-to-EBIT

RLS Global AB (OSTO:RLS) EV-to-EBIT : -1.12 (As of Apr. 30, 2024)


View and export this data going back to 2004. Start your Free Trial

What is RLS Global AB EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, RLS Global AB's Enterprise Value is kr31.05 Mil. RLS Global AB's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was kr-27.83 Mil. Therefore, RLS Global AB's EV-to-EBIT for today is -1.12.

The historical rank and industry rank for RLS Global AB's EV-to-EBIT or its related term are showing as below:

OSTO:RLS' s EV-to-EBIT Range Over the Past 10 Years
Min: -65.85   Med: -17.01   Max: -1.05
Current: -1.12

During the past 13 years, the highest EV-to-EBIT of RLS Global AB was -1.05. The lowest was -65.85. And the median was -17.01.

OSTO:RLS's EV-to-EBIT is not ranked
in the Drug Manufacturers industry.
Industry Median: 17.14 vs OSTO:RLS: -1.12

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. RLS Global AB's Enterprise Value for the quarter that ended in Jun. 2023 was kr65.24 Mil. RLS Global AB's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was kr-27.83 Mil. RLS Global AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -42.66%.


RLS Global AB EV-to-EBIT Historical Data

The historical data trend for RLS Global AB's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RLS Global AB EV-to-EBIT Chart

RLS Global AB Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.76 -12.14 -17.51 -24.08 -7.74

RLS Global AB Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.16 -9.84 -7.74 -6.37 -2.34

Competitive Comparison of RLS Global AB's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, RLS Global AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RLS Global AB's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RLS Global AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where RLS Global AB's EV-to-EBIT falls into.



RLS Global AB EV-to-EBIT Calculation

RLS Global AB's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=31.052/-27.831
=-1.12

RLS Global AB's current Enterprise Value is kr31.05 Mil.
RLS Global AB's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-27.83 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RLS Global AB  (OSTO:RLS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

RLS Global AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2023 ) =EBIT / Enterprise Value (Q: Jun. 2023 )
=-27.831/65.2384878
=-42.66 %

RLS Global AB's Enterprise Value for the quarter that ended in Jun. 2023 was kr65.24 Mil.
RLS Global AB's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-27.83 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RLS Global AB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of RLS Global AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


RLS Global AB (OSTO:RLS) Business Description

Traded in Other Exchanges
N/A
Address
Neongatan 5, Mölndal, SWE, 431 53
RLS Global AB develops and sells biochemical products for the treatment of some of common diseases in wound and dental care.

RLS Global AB (OSTO:RLS) Headlines

No Headlines